Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression-Reference-Cited by-同舟云学术

Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression

Published:2016-02 Issue:1 Volume:36 Page:77-81
ISSN:0271-0749
Container-title:Journal of Clinical Psychopharmacology
language:en
Short-container-title:

Author:

Sanches Rafael Faria,de Lima Osório Flávia,dos Santos Rafael G.,Macedo Ligia R.H.,Maia-de-Oliveira João Paulo,Wichert-Ana Lauro,de Araujo Draulio Barros,Riba Jordi,Crippa José Alexandre S.,Hallak Jaime E.C.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Psychiatry and Mental health

Reference23 articles.

1. Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics.;Riba;J Pharmacol Exp Ther,2003

2. Increased frontal and paralimbic activation following ayahuasca, the pan-Amazonian inebriant.;Riba;Psychopharmacology (Berl),2006

3. Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report.;Osorio;Rev Bras Psiquiatr,2015

4. Reliability of the structured clinical interview for DSM-IVclinical version translated into Portuguese.;Del-Ben;Rev Bras Psiquiatr,2001

5. Hamilton (HAM-D) Montgomery Asberg (MADRS) depression rating scales.;Moreno;Rev Psiquiatr Clin,1998

Cited by 370 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors;Cellular and Molecular Life Sciences;2024-09-10

2. Shared effects of electroconvulsive shocks and ketamine on neuroplasticity: A systematic review of animal models of depression;Neuroscience & Biobehavioral Reviews;2024-09

3. The Antidepressant Effects of Vaporized N,N-Dimethyltryptamine: An Open-Label Pilot Trial in Treatment-Resistant Depression;Psychedelic Medicine;2024-08-09

4. Current Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Efficacy, Limitations and Challenges;CNS Drugs;2024-07-20

5. Serotonergic psychedelic 5-MeO-DMT alters plasticity-related gene expression and generates anxiolytic effects in stressed mice;Molecular Psychiatry;2024-07-05